生物科技
派林生物
000403 · Shenzhen
Latest earnings
2026-10-22Latest company announcements
- 2026-10-22 · Exchange filing第十届董事会第二十五次会议（临时会议）决议公告 ↗
- 2026-10-16 · Exchange filing关于2026年中期利润分配实施的公告 ↗
000403
派斯双林生物制药股份有限公司 (000403), listed on the Shenzhen Stock Exchange, researches, manufactures, and sells plasma-derived blood products. Its 2026 interim report identifies blood products as its principal business.
Loading indicator history…
◆ Earnings◇ Insider trades⬡ Relationships● Business■ Corporate actions＋ Financing✦ Governance○ Other
Events use source publication dates; missing prices are not filled.
Estimated market cap
Unavailable
An official share count and a stored closing price are required. Updated daily.
Annual financials
Annual financials have not been cached yet.
Analyst views
Loading views…
Loading your outlook…
Analyst posts
Publish a viewLoading…
Company overview
派斯双林生物制药股份有限公司 (000403), listed on the Shenzhen Stock Exchange, researches, manufactures, and sells plasma-derived blood products. Its 2026 interim report identifies blood products as its principal business.